WO2000066606A1 - Substrate including anionic detergent for purifying nucleic acid - Google Patents

Substrate including anionic detergent for purifying nucleic acid Download PDF

Info

Publication number
WO2000066606A1
WO2000066606A1 PCT/US2000/010225 US0010225W WO0066606A1 WO 2000066606 A1 WO2000066606 A1 WO 2000066606A1 US 0010225 W US0010225 W US 0010225W WO 0066606 A1 WO0066606 A1 WO 0066606A1
Authority
WO
WIPO (PCT)
Prior art keywords
substrate
nucleic acid
sds
matrix
anionic detergent
Prior art date
Application number
PCT/US2000/010225
Other languages
French (fr)
Inventor
Martin A. Smith
James C. Davis
Mridula Iyer
Original Assignee
Whatman, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whatman, Inc. filed Critical Whatman, Inc.
Priority to AU43535/00A priority Critical patent/AU4353500A/en
Priority to EP00923408A priority patent/EP1175431A4/en
Publication of WO2000066606A1 publication Critical patent/WO2000066606A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers

Definitions

  • the present invention relates to substrates and methods of utilizing substrates for the purification of nucleic acids or other genetic material. More specifically, the present invention relates to the purification of nucleic acids on a filter-based medium from a biological mixture of molecules in a fluid phase. Such purified nucleic acid is suitable for subsequent analysis by methods such as PCR amplification, agarose gel amplification, genotyping, sequencing, restriction digestion, and bacterial transformation.
  • Coated filter material has been shown to be useful as a matrix for the isolation and archiving of nucleic acid. Applicants have recently shown that FTA coated glass microfiber can be used as a tool for the isolation and subsequent elusion of genomic DNA. The components of the FTA coating facilitate this procedure.
  • the FTA coating comprises several components that initiate cell lysis and enable nucleic acid binding.
  • the coating also contributes to stability of the bound material.
  • the FTA coating functionally associates with the filter matrix or media.
  • the coated filter material has been shown to be useful as a tool for the rapid isolation of nucleic acid from whole cells.
  • United States Patents 5,496,562, 5,756,126, and 5,807,527 all relate to FTA coated materials for the isolation of nucleic acid from whole cells.
  • United States Patent Application 09/398,625, assigned to the assignees of the present invention discloses an FTA coated glass microfiber used as a tool for the storage, isolation, and subsequent elution of genomic DNA from whole cell samples.
  • the media employs the use of toxic choatrophic salt to initiate cell rupture and nucleic acid binding.
  • the use of a safe material and a material appropriate for obtaining cellular samples from, for example, delicate neonatal skin, and the use of a filter matrix that inherently binds nucleic acid and avoids the use of choatrophic salts to promote nucleic acid binding is desirable. Such a system would be quite useful and a significant improvement over the prior art.
  • a substrate for purifying nucleic acid consisting of a matrix and an anionic detergent fixed thereto.
  • the present invention further provides a method of preparing a filter matrix consisting of the step of fixing an anionic detergent on a matrix. Further, the present invention provides a method for isolating and archiving nucleic acid by the steps of applying a nucleic acid sample to a substrate consisting of an anionic detergent fixed to a matrix whereby the substrate physically captures the nucleic acid. The nucleic acid is then bound to the substrate.
  • FIGURE 1 shows a Polaroid image of Ameolgenin PCR products from DNA isolated from a variety of filter media and analyzed on a 1.5% agarose gel stained with ethidium bromide
  • lane 1 genomic DNA isolation carried out using GF/C glass microfiber coated with 10% SDS (medium of the invention);
  • lane 2 genomic DNA isolated using GF/C glass microfiber coated with 10% SDS/5.3M GuHC1 ;
  • lane 3 genomic DNA isolated using GF/C glass microfiber coated with FTA (FTA Elute);
  • lane 4 genomic DNA isolated using 31 -ET cellulose coated with FTA;
  • lane 5 no DNA PCR control;
  • FIGURE 2 shows a UVP Gel Documentation image of an agarose gel showing the presence of isolated plasmid DNA from bacterial colonies using a variety of coated filter materials; the three-band pattern of classic plasmid isolation being noted (supercoiled, nicked, and linear), lanes 1 and 2: Plasmid isolated using FTA coated GF/C glass microfiber (FTA Elute); lanes 3 and 4: Plasmid isolated using 10% SDS coated DBS 1000 glass microfiber; lanes 5 and 6: Plasmid isolated using FTA coated glass flake impregnated glass microfiber;
  • FIGURE 3 shows a UVP Gel Documentation image of an agase gel showing the presence of isolated plasmid DNA from liquid culture using a variety of coated filter materials in the GenSpin format; lane 1 : 500ng commercially available pGEM plasmid DNA (Promega); lanes 2-5: Plasmid isolated using FTA coated GF/C glass microfiber (FTA Elute); lanes 6-9: Plasmid isolated using 10% SDS coated DBS1000 glass microfiber; and
  • FIGURE 4 shows a UVP Gel Documentation image of an agarose gel showing the presence of different isolated plasmid DNA populations from liquid culture using a variety of SDS coated and FTA coated filter materials in the 96 well multiwell format; lane 1 : 1% SDS coated DBS1000 presented with pGEM plasmid culture; lane 2: 2.5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 3: 5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 4: 7.5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 5: 10% SDS coated DBS1000 presented with pGEM plasmid culture; lane 6: FTA coated GF/C presented with pGEM plasmid culture; lane 7: 1% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 8: 2.5% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 9: 5% S
  • the present invention provides a substrate for purifying nucleic acid, the substrate consisting of a matrix and an anionic detergent affixed thereto.
  • the source of the nucleic acid can be a biological sample containing whole cells.
  • the whole cell can be, but not restricted to, blood, bacterial culture, bacterial colonies, saliva, urine, drinking water, plasma, stool samples, and sputum.
  • the samples can be collected by various means known in the art, transported to the substrate, and then applied thereto.
  • the substrate can be in the form of a sampling device, such as a swab, sheet material, or the like and the sample can be obtained directly from the source.
  • the substrate can be in the form of a device which can swipe or otherwise obtain the cell sample from a source.
  • the source can be a sample tube containing a liquid sample, an organ, such as a mouth, ear, or other part of a human or animal, a sample pool, such as a blood sample at a crime scene or the like, or other various sources of cells known in the scientific, forensic, and other arts.
  • the substrate consists of a matrix and an anionic detergent affixed thereto.
  • the anionic detergent can be selected from the group including sodium dodecyl sulfate (SDS). SDS can be obtained in various forms, such as the C 12 form and the lauryl sulfate. Other anionic detergents can be used, such as alkyl aryl sulphonates, long chain (fatty alcohol sulphates) olefine sulphates, sulphosuccinates, phosphate ester, sodium tetradecylsulphate and sodium 2-ethylhexysulphate.
  • 5%-10% SDS can be used in accordance with the present invention.
  • a definite optimum SDS concentration is achieved in the 5 - 7.5% SDS concentration range for coating particular glass microfiber in order to enrich for and purify different plasmid populations directly from liquid cultures in a multi-well format, such formats being well known in the art.
  • the matrix can be associated with the anionic detergent in different forms, well known in the coating art.
  • the anionic detergent can impregnate the matrix, such methods of manufacturing to cause impregnation being well known in the art.
  • the anionic detergent can merely coat the matrix, such coating being obtained by methods well known in the art.
  • the matrix can be made from fibers well known in the filtration art.
  • the matrix can include fibers selected from the group including cellulose, glass fibers, glass microfibers, poly(vinylidene fluoride) (PDVF), non-woven polyesters, and melt blown polypropylenes.
  • the anionic detergent, such as the SDS can be applied to the filter matrix at varying concentrations.
  • the fibrous filter matrix of the present invention can be manufactured in various forms.
  • the fibrous filter matrix can be manufactured in a sheet form, which allows for it to be in various formats such as multi-well plates, spin tubes, slides, cartridges, swabs, and pads.
  • substrate or matrix most generally means a porous material or filter media formed, but not limited to, either fully or partly from the materials set forth above, and/or their derivatives.
  • the matrix material does not inhibit the sorption of chemical coating solution and does not inhibit the storage, elusion, and subsequent analysis of nucleic acid containing material added to it. It is preferred that the matrix be of a porous nature to facilitate immobilization of nucleic acid.
  • the substrate of the present invention allows for elusion of the genetic material therefrom in a state that allows for subsequent analysis. Such elusion is a time efficient step thereby providing for almost immediately analysis.
  • the anionic detergent By being fixed to the matrix, the anionic detergent is disposed, sorbed, or otherwise associated with the matrix of the present invention such that the matrix and anionic detergent coating function together to immobilize nucleic acid thereon through an action of cellular lysis of cells presented to the support. That is, the anionic detergent can be adsorbed, absorbed, coated over, or otherwise disposed, in functional relationship with the matrix.
  • the substrate of the present invention is capable of releasing the genetic material immobilized thereon to by a heat elusion step.
  • a heat elusion is accomplished by the exposure of the support having the genetic material stored thereon to heated water, the water being nuclease-free. This capacity to allow for elusion characterizes the various support materials of the present invention.
  • the matrix of the present invention is such that nucleic acid immobilized to it can remain so in a stable form and not exhibit degradation, shearing, endonuclease digestion, or UV damage. Accordingly, the substrate in the present invention can be used to transport and archive nucleic acid samples.
  • the present invention is capable of immobilizing nucleic acid that is collected in the form of a soluble fraction followed a simplified elusion process during which immobilized nucleic acid is released from the matrix of the invention.
  • the matrix of the invention yields nucleic acid of sufficient quality that it does not impair downstream analysis, such as polymerase chain reaction (PCR), ligase chain reaction (LCR), transcripted mediated amplification (TMA), reverse transcriptase initiated PCR, DNA or RNA hybridization techniques, sequencing, and the like.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • TMA transcripted mediated amplification
  • reverse transcriptase initiated PCR DNA or RNA hybridization techniques, sequencing, and the like.
  • Nucleic acid immobilization to a solid support although a suitable template for singular PCR reactions, cannot be measured or detected by traditional techniques such as optical density or fluorescence. Nucleic acid must be in solution for these techniques.
  • Other post-purification techniques wherein nucleic acid is desired in the soluble form includes cloning, hybridization protection assay, bacterial transformation, mammalian transfection, transcription-mediated amplification, and other such methods.
  • the present invention provides nucleic acid in such a soluble form.
  • the present inventive substrate can be prepared by fixing an anionic detergent on a matrix. The fixing step can be achieved by either impregnating the anionic detergent within the matrix or coating the matrix, as discussed above.
  • the present invention provides a method for isolating and archiving nucleic acid by the general steps of applying a nucleic acid sample to a substrate consisting of the anionic detergent fixed to the matrix, the substrate physically capturing the nucleic acid, and then bonding the nucleic acid to the substrate.
  • the bonding step is achieved by heating the substrate having nucleic acid applied thereto, by the method discussed above.
  • the applying step can be achieved by applying whole cells to the substrate.
  • the substrate itself actually induces the lysing of the cells thereby releasing the nucleic acid into the substrate.
  • the substrate presents a vast surface area upon which the nucleic acid is bound.
  • a washing step such as with various buffers set forth in the example section, but not limited thereto, can be achieved and is done after cell lysis.
  • the substrate then physically captures the nucleic acid within the intrastaces thereof.
  • the bound nucleic acid can be released from the substrate for further processing and analysis.
  • the release is achieved by washing steps at elevated temperature, as demonstrated in the examples below.
  • enrichment for different populations of nucleic acid from the same cell source can be achieved using incremental temperature regimes.
  • plasmid DNA can be isolated and enriched from bacterial colonies using the substrate of the present invention.
  • Populations, such as larger populations of supercoiled plasmid, followed by nicked plasmid and finally by linear plasmid migrating to the top of the isolating gel can be achieved utilizing incremental increases in incubation temperature.
  • the FTA coating cocktail of the prior art contains 2% SDS. It is unlikely that this percentage can be increased due to saturation points when in conjunction with other components of the cocktail. This limits the lysing capability of the FTA coating filters of the prior art as a critical micelle concentration of SDS can be easily reached when presented with large numbers of cells, such as with a bacterial colony. Therefore, substrates containing a greater concentration of the lytic agent, the anionic detergent, enable greater lysing capability and in turn, greater nucleic acid recoveries. This is demonstrated in the examples set forth below.
  • the following examples demonstrate the preparation, function, and utility of the present invention in order to isolate nucleic acid from various sources.
  • the examples further demonstrate the effect of SDS coating concentrations on glass microfiber for the purification of direct plasmids from direct liquid culture using a multiwell filter plate.
  • the following examples demonstrate that the present invention can be used for the rapid purification and isolation of nucleic acids and genetic material from samples containing whole cells.
  • Example 1 The Use of 10% SDS Coated Glass Microfiber For The Purification Of Genomic DNA From Whole Blood Samples:
  • GF/C glass microfiber was cut to size and pieces soaked in a dish for one hour at room temperature in a solution of either 10% SDS (filter matrix of the invention) or 10% SDS/5.3M GuHC1. After soaking the wetted filters were placed in a convection oven and heated for thirty minutes at 80°C. This soaking and baking process constitutes the coating process. To the coated filter materials, as well as FTA coated GF/C and FTA coated 31 -ET cellulose, several drops of freshly finger stick drawn blood was spotted and allowed to air dry for two minutes. Once dried a 1 mm punch was taken from the dried blood spots and applied to individual 200ul polypropylene PCR tubes.
  • FTA Purification Reagent (0.29g NaCI, 5ml 1M Tris pH 7.5, 1ml 0.5M EDTA, 2.5ml Triton X-100, per 500ml) (Fitzco, Inc.) was added. Tubes were incubated for five minutes at room temperature with no shaking. Following incubation of the FTA Purification Reagent was aspirated from the tube. A second aliquot of 200ul of FTA Purification Reagent was added to each tube. The tubes were incubated for five minutes at room temperature without shaking. Following incubation, the FTA Purifcation Reagent was aspirated from all the tubes.
  • TE 10mM Tris-HCI, 0.1mM EDTA, pH 8.0
  • 20ul of nuclease free water was then applied to every tube.
  • Each tube was then administered to a thermal cycler and heated to 95°C for ten minutes. Following heat incubation the 20ul of water was removed and dispensed into individual 25ul Amelogenin PCR reactions.
  • PCR amplification was carried out following parameters described by the manufacturer of the Amelogenin primer set (Promega). Following PCR 10ul of each PCR reaction was visualized on a 1.5% agarose gel stained with ethidium bromide, and photographed using a Polaroid camera.
  • Lane 1 is GF/C glass microfiber coated with 10% SDS (filter media of this invention) and lane 3 is FTA coated glass microfiber.
  • 10% SDS coated GF/C functions in terms of lysis, binding, and elution as well as the FTA coated GF/C.
  • the advantage is that one does not have to manufacture the 10% SDS GF/C with the same level of control as the FTA coated GF/C which has multiple components within the FTA cocktail.
  • PCR-ready genomic DNA has not been released from glass microfiber coated with a mixture of 10% SDS and 5.3M GuHC1 (lane 2), and FTA coated 31-ET cellulose (lane 4).
  • the non-appearance of PCR product in lanes 3 and 4 may be due to the inability of the filter material and coating to lyse cells. More probably, this effect is caused by an inability of the filter material and coating to release the bound genomic DNA after lysing (U.S. Patents 5,496,562, 5,756,126, 5,807,527).
  • Lane 5 is a no DNA PCR control.
  • DH5 ⁇ bacterial culture was transformed with the plasmid pGEM and streaked onto an LB medium petri dish. Following overnight incubation of the streaked petri dish at 37°C, individual bacterial colonies were picked and resuspended in 10ul of PBS buffer. The resuspended colonies were then spotted to 7mm discs of either FTA coated GF/C glass microfiber, 10% SDS coated DBS1000 glass microfiber (the medium of the invention), and FTA coated glass flake impregnated glass microfiber. After spotting, the discs were placed into a 2ml Eppendorf tube.
  • TE buffer containing 10ug/ml Rnase was added and incubated for five minutes at room temperature without shaking. After incubation, the TE/Rnase buffer was aspirated from the tubes and replaced with 1ml of TE buffer an dincubated for five minutes at room temperature without shaking. Again, TE was aspirated and replaced with fresh TE buffer following incubation. Following the final TE buffer incubation, 200ul of nuclease free water was added to each disc and incubated at 65°C for fifteen minutes. Applicants have previously shown (Iyer, M. et al. (2000) Rapid Plasmid Template Preparation using Novel Paper Based Systems. Abstract & Poster.
  • plasmid DNA can be isolated and enriched for from bacterial colonies using coated filter media.
  • the classic three-band appearance of plasmic on the gel is noted (larger populations of supercoiled plasmid, followed by nicked plasmid and finally linear plasmid migrating at the top of the tel).
  • FTA coating cocktail contains 2% SDS, and that this percentage is unlikely to be increased due to saturation points when in conjunction with other components of the cocktail.
  • TE buffer containing 10ug/ml of Rnase was added and incubated for one minute at room temperature before centrifugation at 12,000 xg for one minute.
  • the TE step was repeated twice more (without Rnase).
  • 200ul of nuclease free water was added to the spin basket of each set of GenSpin tubes. Tubes were then incubated at 55°C for fifteen minutes in a water bath. Following heat incubation, the tubes were subjected to a final centrifugation step at 12,000 xg for two minutes. 20ul of the final filtrate was analyzed by agarose gel electrophoresis. The ethidium bromide stain agarose gel image was captured using UVP Gel Documentation System.
  • SDS coated filter material in the GenSpin format, Applicants have been able to purify high quality plasmid DNA directly from liquid culture without the need for cell harvesting, lysis, precipitation and binding that is required for traditional chaotrophic salt plasmid isolations. Furthermore, the SDS coated material is more effective at purifying plasmid directly from liquid culture than FTA coated filter material.
  • Example 4 Effect Of SDS Coating Concentration On Glass Microfiber For the Purification Of Different Plasmids From Direct Liquid Culture Using A Multiwell Filterplate
  • DH5 ⁇ bacterial cells were transformed with either pGEM, pUC19, or pGEM.SPORT plasmids and grown overnight in separate 10ml LB cultures at 37°C with constant shaking. To each well of the filled multiwell plate, a 500ul aliquot of the bacterial culture was added.
  • the multiwell plate was placed on top of a multiwell collection plate and centrifuged at 1000 xg for two minutes so as to transfer the nuclease free water within the filter multiwell plate to the collection plate. 20ul of the final filtrate was analyzed by agarose gel electrophoresis. The ethidium bromide stained agarose gel image was captured using UVP Gel Documentation System.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A substrate for purifying nucleic acid and enriching for populations of nucleic acids from a single cell source consists of a matrix and anionic detergent affixed thereto. A method of making the substrate includes the steps of affixing an anionic detergent to the matrix. A method for isolating and archiving nucleic acid utilizing the matrix includes the steps of applying the nucleic acid sample to the substrate, the substrate physically capturing the nucleic acid and bonding the nucleic acid to the substrate.

Description

SUBSTRATE INCLUDING ANIONIC DETERGENT FOR PURIFYING NUCLEIC ACID
TECHNICAL FIELD
The present invention relates to substrates and methods of utilizing substrates for the purification of nucleic acids or other genetic material. More specifically, the present invention relates to the purification of nucleic acids on a filter-based medium from a biological mixture of molecules in a fluid phase. Such purified nucleic acid is suitable for subsequent analysis by methods such as PCR amplification, agarose gel amplification, genotyping, sequencing, restriction digestion, and bacterial transformation.
BACKGROUND OF THE INVENTION
Coated filter material has been shown to be useful as a matrix for the isolation and archiving of nucleic acid. Applicants have recently shown that FTA coated glass microfiber can be used as a tool for the isolation and subsequent elusion of genomic DNA. The components of the FTA coating facilitate this procedure.
The FTA coating comprises several components that initiate cell lysis and enable nucleic acid binding. The coating also contributes to stability of the bound material.
The FTA coating functionally associates with the filter matrix or media. The coated filter material has been shown to be useful as a tool for the rapid isolation of nucleic acid from whole cells. For example, the United States Patents 5,496,562, 5,756,126, and 5,807,527 all relate to FTA coated materials for the isolation of nucleic acid from whole cells. United States Patent Application 09/398,625, assigned to the assignees of the present invention, discloses an FTA coated glass microfiber used as a tool for the storage, isolation, and subsequent elution of genomic DNA from whole cell samples.
There are several problems associated with the filter media described in United States Patent 5,939,259. The media employs the use of toxic choatrophic salt to initiate cell rupture and nucleic acid binding. The use of a safe material and a material appropriate for obtaining cellular samples from, for example, delicate neonatal skin, and the use of a filter matrix that inherently binds nucleic acid and avoids the use of choatrophic salts to promote nucleic acid binding is desirable. Such a system would be quite useful and a significant improvement over the prior art.
It would also be useful to develop a filter material which enhances yields of eluted plasmid purification products from bacterial cultures. It would be desirable to obtain greater critical micelle concentration which thereby would generate greater lysing capability and greater yields of target nucleic acid.
Summary of the Invention
In accordance with the present invention, there is provided a substrate for purifying nucleic acid consisting of a matrix and an anionic detergent fixed thereto.
The present invention further provides a method of preparing a filter matrix consisting of the step of fixing an anionic detergent on a matrix. Further, the present invention provides a method for isolating and archiving nucleic acid by the steps of applying a nucleic acid sample to a substrate consisting of an anionic detergent fixed to a matrix whereby the substrate physically captures the nucleic acid. The nucleic acid is then bound to the substrate.
Brief Description of the Drawings
Other advantages of the present invention will be readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings wherein:
FIGURE 1 shows a Polaroid image of Ameolgenin PCR products from DNA isolated from a variety of filter media and analyzed on a 1.5% agarose gel stained with ethidium bromide, lane 1 : genomic DNA isolation carried out using GF/C glass microfiber coated with 10% SDS (medium of the invention); lane 2: genomic DNA isolated using GF/C glass microfiber coated with 10% SDS/5.3M GuHC1 ; lane 3: genomic DNA isolated using GF/C glass microfiber coated with FTA (FTA Elute); lane 4: genomic DNA isolated using 31 -ET cellulose coated with FTA; lane 5: no DNA PCR control;
FIGURE 2 shows a UVP Gel Documentation image of an agarose gel showing the presence of isolated plasmid DNA from bacterial colonies using a variety of coated filter materials; the three-band pattern of classic plasmid isolation being noted (supercoiled, nicked, and linear), lanes 1 and 2: Plasmid isolated using FTA coated GF/C glass microfiber (FTA Elute); lanes 3 and 4: Plasmid isolated using 10% SDS coated DBS 1000 glass microfiber; lanes 5 and 6: Plasmid isolated using FTA coated glass flake impregnated glass microfiber;
FIGURE 3 shows a UVP Gel Documentation image of an agase gel showing the presence of isolated plasmid DNA from liquid culture using a variety of coated filter materials in the GenSpin format; lane 1 : 500ng commercially available pGEM plasmid DNA (Promega); lanes 2-5: Plasmid isolated using FTA coated GF/C glass microfiber (FTA Elute); lanes 6-9: Plasmid isolated using 10% SDS coated DBS1000 glass microfiber; and
FIGURE 4 shows a UVP Gel Documentation image of an agarose gel showing the presence of different isolated plasmid DNA populations from liquid culture using a variety of SDS coated and FTA coated filter materials in the 96 well multiwell format; lane 1 : 1% SDS coated DBS1000 presented with pGEM plasmid culture; lane 2: 2.5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 3: 5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 4: 7.5% SDS coated DBS1000 presented with pGEM plasmid culture; lane 5: 10% SDS coated DBS1000 presented with pGEM plasmid culture; lane 6: FTA coated GF/C presented with pGEM plasmid culture; lane 7: 1% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 8: 2.5% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 9: 5% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 10: 7.5% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 11 : 10% SDS coated DBS1000 presented with pUC19 plasmid culture; lane 12: FTA coted GF/C presented with pUC19 plasmid culture; lane 13: 1% SDS coated DBS1000 presented with pGEM.SPORT plasmid culture; lane 14: 2.5% SDS coated DBS1000 presented with pGEM.SPORT plasmid culture; lane 15: 5% SDS coated DBS1000 presented with pGEM.SPORT plasmid culture; lane 16: 7.5% SDS coated DBS1000 presented with pGEM.SPORT plasmid culture; lane 17: 10% SDS coated DBS1000 presented with pGEM.SPORT plasmid culture; lane 18: FTA coated GF/C presented with pGEM.SPORT plasmid culture; MW: 1kb ladder molecular weight markers (Life Technologies).
Detailed Description of the Invention
Generally, the present invention provides a substrate for purifying nucleic acid, the substrate consisting of a matrix and an anionic detergent affixed thereto.
The source of the nucleic acid can be a biological sample containing whole cells. The whole cell can be, but not restricted to, blood, bacterial culture, bacterial colonies, saliva, urine, drinking water, plasma, stool samples, and sputum. The samples can be collected by various means known in the art, transported to the substrate, and then applied thereto. Alternatively, the substrate can be in the form of a sampling device, such as a swab, sheet material, or the like and the sample can be obtained directly from the source. In other words, the substrate can be in the form of a device which can swipe or otherwise obtain the cell sample from a source. The source can be a sample tube containing a liquid sample, an organ, such as a mouth, ear, or other part of a human or animal, a sample pool, such as a blood sample at a crime scene or the like, or other various sources of cells known in the scientific, forensic, and other arts.
The substrate consists of a matrix and an anionic detergent affixed thereto. The anionic detergent can be selected from the group including sodium dodecyl sulfate (SDS). SDS can be obtained in various forms, such as the C12 form and the lauryl sulfate. Other anionic detergents can be used, such as alkyl aryl sulphonates, long chain (fatty alcohol sulphates) olefine sulphates, sulphosuccinates, phosphate ester, sodium tetradecylsulphate and sodium 2-ethylhexysulphate.
Generally, 5%-10% SDS can be used in accordance with the present invention. For example, increased concentrations of SDS, up to 10%, which cannot be accommodated within an FTA cocktail, as set forth in the prior art patents discussed above, provided greater critical micelle concentration which generates greater lysing capability and thus greater yield of target nucleic acid, as demonstrated in the example section set forth below. As specifically shown in Example 4, below, a definite optimum SDS concentration is achieved in the 5 - 7.5% SDS concentration range for coating particular glass microfiber in order to enrich for and purify different plasmid populations directly from liquid cultures in a multi-well format, such formats being well known in the art.
The matrix can be associated with the anionic detergent in different forms, well known in the coating art. For example, the anionic detergent can impregnate the matrix, such methods of manufacturing to cause impregnation being well known in the art. Alternatively, the anionic detergent can merely coat the matrix, such coating being obtained by methods well known in the art.
The matrix can be made from fibers well known in the filtration art. The matrix can include fibers selected from the group including cellulose, glass fibers, glass microfibers, poly(vinylidene fluoride) (PDVF), non-woven polyesters, and melt blown polypropylenes. The anionic detergent, such as the SDS, can be applied to the filter matrix at varying concentrations. The fibrous filter matrix of the present invention can be manufactured in various forms. For example, the fibrous filter matrix can be manufactured in a sheet form, which allows for it to be in various formats such as multi-well plates, spin tubes, slides, cartridges, swabs, and pads.
The term substrate or matrix, as used above, most generally means a porous material or filter media formed, but not limited to, either fully or partly from the materials set forth above, and/or their derivatives. The matrix material does not inhibit the sorption of chemical coating solution and does not inhibit the storage, elusion, and subsequent analysis of nucleic acid containing material added to it. It is preferred that the matrix be of a porous nature to facilitate immobilization of nucleic acid. Similar to the disclosure in United States Patent Application 09/398,625 discussed above, the substrate of the present invention allows for elusion of the genetic material therefrom in a state that allows for subsequent analysis. Such elusion is a time efficient step thereby providing for almost immediately analysis.
By being fixed to the matrix, the anionic detergent is disposed, sorbed, or otherwise associated with the matrix of the present invention such that the matrix and anionic detergent coating function together to immobilize nucleic acid thereon through an action of cellular lysis of cells presented to the support. That is, the anionic detergent can be adsorbed, absorbed, coated over, or otherwise disposed, in functional relationship with the matrix.
The substrate of the present invention is capable of releasing the genetic material immobilized thereon to by a heat elusion step. Preferably, such a heat elusion is accomplished by the exposure of the support having the genetic material stored thereon to heated water, the water being nuclease-free. This capacity to allow for elusion characterizes the various support materials of the present invention.
The matrix of the present invention is such that nucleic acid immobilized to it can remain so in a stable form and not exhibit degradation, shearing, endonuclease digestion, or UV damage. Accordingly, the substrate in the present invention can be used to transport and archive nucleic acid samples.
For the present invention to be useful in various arts, it is capable of immobilizing nucleic acid that is collected in the form of a soluble fraction followed a simplified elusion process during which immobilized nucleic acid is released from the matrix of the invention. The matrix of the invention yields nucleic acid of sufficient quality that it does not impair downstream analysis, such as polymerase chain reaction (PCR), ligase chain reaction (LCR), transcripted mediated amplification (TMA), reverse transcriptase initiated PCR, DNA or RNA hybridization techniques, sequencing, and the like.
Nucleic acid immobilization to a solid support, although a suitable template for singular PCR reactions, cannot be measured or detected by traditional techniques such as optical density or fluorescence. Nucleic acid must be in solution for these techniques. Other post-purification techniques wherein nucleic acid is desired in the soluble form includes cloning, hybridization protection assay, bacterial transformation, mammalian transfection, transcription-mediated amplification, and other such methods. The present invention provides nucleic acid in such a soluble form. The present inventive substrate can be prepared by fixing an anionic detergent on a matrix. The fixing step can be achieved by either impregnating the anionic detergent within the matrix or coating the matrix, as discussed above.
The present invention provides a method for isolating and archiving nucleic acid by the general steps of applying a nucleic acid sample to a substrate consisting of the anionic detergent fixed to the matrix, the substrate physically capturing the nucleic acid, and then bonding the nucleic acid to the substrate. The bonding step is achieved by heating the substrate having nucleic acid applied thereto, by the method discussed above.
The applying step can be achieved by applying whole cells to the substrate. The substrate itself actually induces the lysing of the cells thereby releasing the nucleic acid into the substrate. By being a porous substrate, the substrate presents a vast surface area upon which the nucleic acid is bound.
A washing step, such as with various buffers set forth in the example section, but not limited thereto, can be achieved and is done after cell lysis. The substrate then physically captures the nucleic acid within the intrastaces thereof.
The bound nucleic acid can be released from the substrate for further processing and analysis. The release is achieved by washing steps at elevated temperature, as demonstrated in the examples below. Unexpectedly, as demonstrated in Example 2, enrichment for different populations of nucleic acid from the same cell source can be achieved using incremental temperature regimes. For example, as demonstrated in Example 2, plasmid DNA can be isolated and enriched from bacterial colonies using the substrate of the present invention. Populations, such as larger populations of supercoiled plasmid, followed by nicked plasmid and finally by linear plasmid migrating to the top of the isolating gel can be achieved utilizing incremental increases in incubation temperature.
It is known that the FTA coating cocktail of the prior art contains 2% SDS. It is unlikely that this percentage can be increased due to saturation points when in conjunction with other components of the cocktail. This limits the lysing capability of the FTA coating filters of the prior art as a critical micelle concentration of SDS can be easily reached when presented with large numbers of cells, such as with a bacterial colony. Therefore, substrates containing a greater concentration of the lytic agent, the anionic detergent, enable greater lysing capability and in turn, greater nucleic acid recoveries. This is demonstrated in the examples set forth below.
The following examples demonstrate the preparation, function, and utility of the present invention in order to isolate nucleic acid from various sources. The examples further demonstrate the effect of SDS coating concentrations on glass microfiber for the purification of direct plasmids from direct liquid culture using a multiwell filter plate. Hence, the following examples demonstrate that the present invention can be used for the rapid purification and isolation of nucleic acids and genetic material from samples containing whole cells.
Examples
Example 1. The Use of 10% SDS Coated Glass Microfiber For The Purification Of Genomic DNA From Whole Blood Samples:
GF/C glass microfiber was cut to size and pieces soaked in a dish for one hour at room temperature in a solution of either 10% SDS (filter matrix of the invention) or 10% SDS/5.3M GuHC1. After soaking the wetted filters were placed in a convection oven and heated for thirty minutes at 80°C. This soaking and baking process constitutes the coating process. To the coated filter materials, as well as FTA coated GF/C and FTA coated 31 -ET cellulose, several drops of freshly finger stick drawn blood was spotted and allowed to air dry for two minutes. Once dried a 1 mm punch was taken from the dried blood spots and applied to individual 200ul polypropylene PCR tubes. To each tube containing a single 1mm punch, 200ul of FTA Purification Reagent (0.29g NaCI, 5ml 1M Tris pH 7.5, 1ml 0.5M EDTA, 2.5ml Triton X-100, per 500ml) (Fitzco, Inc.) was added. Tubes were incubated for five minutes at room temperature with no shaking. Following incubation of the FTA Purification Reagent was aspirated from the tube. A second aliquot of 200ul of FTA Purification Reagent was added to each tube. The tubes were incubated for five minutes at room temperature without shaking. Following incubation, the FTA Purifcation Reagent was aspirated from all the tubes. 200ul of TE (10mM Tris-HCI, 0.1mM EDTA, pH 8.0) buffer was then added to each tube. The tubes were incubated for five minutes at room temperature without shaking. The TE buffer was fully removed from the tubes, leaving the now washed 1mm discs at the bottom of the respective tubes. 20ul of nuclease free water was then applied to every tube. Each tube was then administered to a thermal cycler and heated to 95°C for ten minutes. Following heat incubation the 20ul of water was removed and dispensed into individual 25ul Amelogenin PCR reactions. PCR amplification was carried out following parameters described by the manufacturer of the Amelogenin primer set (Promega). Following PCR 10ul of each PCR reaction was visualized on a 1.5% agarose gel stained with ethidium bromide, and photographed using a Polaroid camera.
It can be seen from the Amelogenin amplification results (Figure 1) that PCR product is noted in lanes 1 and 3. This illustrates that readily genomic DNA has been isolated and eluted from the filter media represented in these lanes. Lane 1 is GF/C glass microfiber coated with 10% SDS (filter media of this invention) and lane 3 is FTA coated glass microfiber. We see that 10% SDS coated GF/C functions in terms of lysis, binding, and elution as well as the FTA coated GF/C. The advantage is that one does not have to manufacture the 10% SDS GF/C with the same level of control as the FTA coated GF/C which has multiple components within the FTA cocktail.
From Figure 1 it can be noted that PCR-ready genomic DNA has not been released from glass microfiber coated with a mixture of 10% SDS and 5.3M GuHC1 (lane 2), and FTA coated 31-ET cellulose (lane 4). The non-appearance of PCR product in lanes 3 and 4 may be due to the inability of the filter material and coating to lyse cells. More probably, this effect is caused by an inability of the filter material and coating to release the bound genomic DNA after lysing (U.S. Patents 5,496,562, 5,756,126, 5,807,527). Lane 5 is a no DNA PCR control.
Example 2. Comparison of FTA Coated Filter Materials And A 10% SDS Coated Filter Material For The Purification Of Bacterial Plasmid DNA From Single Colonies:
DH5α bacterial culture was transformed with the plasmid pGEM and streaked onto an LB medium petri dish. Following overnight incubation of the streaked petri dish at 37°C, individual bacterial colonies were picked and resuspended in 10ul of PBS buffer. The resuspended colonies were then spotted to 7mm discs of either FTA coated GF/C glass microfiber, 10% SDS coated DBS1000 glass microfiber (the medium of the invention), and FTA coated glass flake impregnated glass microfiber. After spotting, the discs were placed into a 2ml Eppendorf tube. To each disc, 1ml of TE buffer containing 10ug/ml Rnase was added and incubated for five minutes at room temperature without shaking. After incubation, the TE/Rnase buffer was aspirated from the tubes and replaced with 1ml of TE buffer an dincubated for five minutes at room temperature without shaking. Again, TE was aspirated and replaced with fresh TE buffer following incubation. Following the final TE buffer incubation, 200ul of nuclease free water was added to each disc and incubated at 65°C for fifteen minutes. Applicants have previously shown (Iyer, M. et al. (2000) Rapid Plasmid Template Preparation using Novel Paper Based Systems. Abstract & Poster. Plant and Animal Genome VIII Meeting, San Diego, California) that 65°C incubation preferentially elutes smaller plasmid DNA populations from FTA coated filter materials, enriching over larger bacterial genomic DNA populations that will be bound as a result of the initial lysis step upon cell contact with the coated filter material. Bacterial genomic DNA requires a higher temperature than 65°C in order to be released from the coated paper.
After heat incubation the 200ul fraction from each tube was removed and 20ul of it analyzed by agarose gel electrophoresis. The ethidium bromide stain agarose gel image was captured using UVP Gel Documentation System.
From the gel image in Figure 2 it can be clearly seen that plasmid DNA can be isolated and enriched for from bacterial colonies using coated filter media. The classic three-band appearance of plasmic on the gel is noted (larger populations of supercoiled plasmid, followed by nicked plasmid and finally linear plasmid migrating at the top of the tel). Of particular note is the greater yield apparent when 10% SDS coated glass microfiber is utilized compared to FTA coated matrices. FTA coating cocktail contains 2% SDS, and that this percentage is unlikely to be increased due to saturation points when in conjunction with other components of the cocktail. This probably limits the lysing capability of FTA coated filters as the critical micelle concentration of SDS can be easily reached when presented with large numbers of cells (such as a bacterial colony). Therefore, filters containing a greater concentration of the lytic agent (SDS) enable greater lysing capability and in turn greater nucleic acid recoveries. This example also demonstrates that the other components of the FTA cocktail are not required for efficient plasmid isolation. This means cheaper, simpler plasmid isolation filter and system could be manufactured.
Example 3. Direct Comparison of 10% SDS Coated Glass Microfiber And The FTA Elute Material Within The GenSpin Product For The Purification Of Plasmid DNA From Direct Liquid Culture
10ml of liquid LB media was inoculated with a single colony of DH5 bacteria transformed with pGEM plasmid. The liquid culture was incubated overnight at 37°C with constant shaking. After incubation 1ml aliquots of the grown bacterial culture were applied to the spin baskets of separate GenSpin tubes (Whatman, Inc.) and also GenSpin tubes which had had the original FTA Elute filter paper replaced with 10% SDS coated DBS1000 glass microfiber. Each tube type was carried out in quadruplicate. Both sets of tubes were centrifuged at 12,000 xg for one minute, and the filtrate removed. To the tubes, 0.5ml of TE buffer containing 10ug/ml of Rnase was added and incubated for one minute at room temperature before centrifugation at 12,000 xg for one minute. The TE step was repeated twice more (without Rnase). After the final TE wash, 200ul of nuclease free water was added to the spin basket of each set of GenSpin tubes. Tubes were then incubated at 55°C for fifteen minutes in a water bath. Following heat incubation, the tubes were subjected to a final centrifugation step at 12,000 xg for two minutes. 20ul of the final filtrate was analyzed by agarose gel electrophoresis. The ethidium bromide stain agarose gel image was captured using UVP Gel Documentation System.
From the UVP Gel Documentation System image of figure 3, both sets of coated filter material in the GenSpin format purify and enrich for plasmid DNA populations within the liquid culture they were presented with. Compared with Figure 2, heat incubation at the lower 55°C temperature produces more intact plasmid DNA (one supercoiled band noted). As seen in lanes 6-9, the 10% SDS coated DBS1000 glass microfiber has greater yields of plasmid DNA than FTA coated GF/C (FTA Elute material within the commercially available GenSpin), as seen in lanes 2-5. The 10% SDS coated material produce plasmid DNA that has a greater ratio of supercoiled DNA compared to the FTA coated material. This is illustrated by the presence of a single band.
By using an SDS coated filter material in the GenSpin format, Applicants have been able to purify high quality plasmid DNA directly from liquid culture without the need for cell harvesting, lysis, precipitation and binding that is required for traditional chaotrophic salt plasmid isolations. Furthermore, the SDS coated material is more effective at purifying plasmid directly from liquid culture than FTA coated filter material. Example 4. Effect Of SDS Coating Concentration On Glass Microfiber For the Purification Of Different Plasmids From Direct Liquid Culture Using A Multiwell Filterplate
Into the empty wells of an 800ul 96 well filterplate, discs of SDS coated DBS1000 glass microfiber were placed. The SDS concentrations of the placed discs were as follows: 1%, 2.5%, 5%, 7.5% and 10%. Also, some wells were filled with a disc of FTA coated GF/C glass microfiber (FTA Elute). DH5α bacterial cells were transformed with either pGEM, pUC19, or pGEM.SPORT plasmids and grown overnight in separate 10ml LB cultures at 37°C with constant shaking. To each well of the filled multiwell plate, a 500ul aliquot of the bacterial culture was added. Addition of culture was carried out in such a way so that all the different filter materials under examination were presented with each of the bacterial cultures. After liquid sample application, the multiwell plate was placed on a vacuum manifold and vacuum applied for five minutes at -25inHg so that the wells could drain. With the vacuum remaining on, the following buffers were added in sequence: 0.5ml TE containing 10ug/ml Rnase, 0.5ml TE buffer, and 0.5ml TE buffer. After the final TE buffer wash, 100ul of nuclease free water was added to each well under examination. The multiwell plate was then placed into a convection oven and incubated for fifteen minutes at 65°C. Following heat incubation the multiwell plate was placed on top of a multiwell collection plate and centrifuged at 1000 xg for two minutes so as to transfer the nuclease free water within the filter multiwell plate to the collection plate. 20ul of the final filtrate was analyzed by agarose gel electrophoresis. The ethidium bromide stained agarose gel image was captured using UVP Gel Documentation System.
From the UVP Gel Documentation System image of Figure 4, it can be readily noted that all of the SDS coated and FTA filter materials enrich for and purify different plasmid populations directly from liquid culture in a multiwell format. There is a definite optimum SDS concentration for the coating on DBS1000 glass microfiber. It appears to be in the 5-7.5% SDS concentration range. At these concentrations, critical micelle concentration is maintained so that lysis is effective and yields high. At lower concentrations, it could be argued that critical micelle concentration is reached and lysis effectiveness is reduced. At higher SDS concentrations, the desired DNA may be damaged in some way such as denaturation. Applicants have therefore demonstrated an optimal SDS concentration for the coating of filter materials when used for the rapid isolation of plasmid DNA directly from liquid culture in a multiwell format.
Throughout this application, various publications, are referenced by author and year. Full citations for the publications are listed below. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
The invention has been described in an illustrative manner, and it is to be understood that the terminology which has been used is intended to be in the nature of words of description rather than of limitation.
Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is, therefore, to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.

Claims

1. A substrate for purifying nucleic acid consisting of a matrix and an anionic detergent affixed thereto.
2. The substrate as in claim 1 wherein said anionic detergent is selected from the group consisting of sodium dodecyl sulfate (SDS).
3. The substrate as in claim 2, wherein said SDS is selected from the group consisting of SDS (C12) and SDS (lauryl), alkyl aryl sulphonates, long chain (fatty) alcohol sulphates, olefine sulphates, sulphosuccinates, phosphate esters, sodium tetradecylsulphate and sodium 2-ethylhexysuiphate.
The substrate as in claim 2, including about 5 to 10%
SDS.
5. The substrate as in claim 1 , wherein said anionic detergent impregnates said matrix.
6. The substrate as in claim 1 , wherein said anionic detergent coats said matrix.
7. The substrate as in claim 1 , wherein said matrix consists of fibers selected from the group consisting of cellulose, glass fibers, glass microfibers, poly(vinylidine fluoride) (PDVF), non-woven polyesters, and melt blown polypropylenes.
8, A method of preparing a filter matrix consisting of the step of fixing an anionic detergent on a matrix.
9. The method as in claim 8, wherein said fixing step is further defined as fixing an anionic detergent selected from the group consisting of SDS (C12) and SDS (lauryl).
10. The method as in claim 8 wherein said fixing step is further defined as impregnating the anionic detergent within the matrix.
11. The method as in claim 8, wherein said fixing step is further defined as coating the anionic detergent over the matrix.
12. A method for isolating and archiving nucleic acid by applying a nucleic acid sample to a substrate consisting of an anionic detergent fixed to a matrix; the substrate physically capturing the nucleic acid, and bonding the nucleic acid to the substrate.
13. The method as in claim 12, wherein said bonding step is further defined as heating the substrate having the nucleic acid applied thereto.
14. The method as in claim 13, wherein said applying step is further defined as applying whole cells to the substrate, the substrate lysing the cells and releasing the nucleic acid onto the substrate.
15. The method as in claim 14, further including the steps of washing the substrate after cell lysis and physical capturing of the nucleic acid by the substrate.
16. A method as in claim 12, further including the steps of releasing the captured nucleic acid from the substrate for further processing and analysis.
17. A method as in claim 16, wherein said releasing step is further defined by enriching one nucleic acid population over another during said releasing step.
18. A method as in claim 17, wherein said enriching step is further defined by incrementally increasing the temperature of incubation during said releasing step to and eluting different populations of nucleic acid at each increment of temperature.
19. A method of claim 12, wherein said applying step is further defined as applying plasmid samples directly from liquid cultures to the substrate and purifying plasmid DNA without the steps of cell harvesting, lysis, precipitation and binding.
PCT/US2000/010225 1999-04-30 2000-04-14 Substrate including anionic detergent for purifying nucleic acid WO2000066606A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU43535/00A AU4353500A (en) 1999-04-30 2000-04-14 Substrate including anionic detergent for purifying nucleic acid
EP00923408A EP1175431A4 (en) 1999-04-30 2000-04-14 Substrate including anionic detergent for purifying nucleic acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13190999P 1999-04-30 1999-04-30
US60/131,909 1999-04-30

Publications (1)

Publication Number Publication Date
WO2000066606A1 true WO2000066606A1 (en) 2000-11-09

Family

ID=22451555

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010225 WO2000066606A1 (en) 1999-04-30 2000-04-14 Substrate including anionic detergent for purifying nucleic acid

Country Status (3)

Country Link
EP (1) EP1175431A4 (en)
AU (1) AU4353500A (en)
WO (1) WO2000066606A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106031A1 (en) * 2002-06-12 2003-12-24 F. Hoffmann-La Roche Ag Method and device for detecting the presence of an analyte in a test sample
EP1436405A2 (en) * 2001-08-20 2004-07-14 Whatman Inc. Dna purification and recovery from high particulate and solids samples
EP1451320A2 (en) * 2001-11-15 2004-09-01 Whatman Inc. Materials and methods for releasing genetic material
EP1453484A2 (en) * 2001-11-15 2004-09-08 Whatman, Inc. Methods and materials for detecting genetic material
JP2013515494A (en) * 2009-12-29 2013-05-09 ワットマン インコーポレイテッド Improved nucleic acid elution
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
CN105907751A (en) * 2016-06-27 2016-08-31 河南农业大学 FTA (flinders technology associates)-card-based method for extracting Cryptosporidium oocyst DNA from feces
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US10435735B2 (en) 2014-03-07 2019-10-08 Dna Genotek Inc. Composition and method for stabilizing nucleic acids in biological samples
US10638963B2 (en) 2017-01-10 2020-05-05 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
US11002646B2 (en) 2011-06-19 2021-05-11 DNA Genotek, Inc. Devices, solutions and methods for sample collection
US11266337B2 (en) 2015-09-09 2022-03-08 Drawbridge Health, Inc. Systems, methods, and devices for sample collection, stabilization and preservation
US11572581B2 (en) 2002-06-07 2023-02-07 DNA Genotek, Inc. Compositions and methods for obtaining nucleic acids from sputum

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496562A (en) * 1988-10-05 1996-03-05 Flinders Technologies Pty Ltd Solid medium and method for DNA storage
US5756126A (en) * 1991-05-29 1998-05-26 Flinders Technologies Pty. Ltd. Dry solid medium for storage and analysis of genetic material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496562A (en) * 1988-10-05 1996-03-05 Flinders Technologies Pty Ltd Solid medium and method for DNA storage
US5756126A (en) * 1991-05-29 1998-05-26 Flinders Technologies Pty. Ltd. Dry solid medium for storage and analysis of genetic material

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MAATMAN ET AL.: "Purification of bacterial artificial chromosome (BAC) DNA using QIAGEN plasmid kit", QIAGEN NEWS,, no. 4, 1996, pages 10 - 11, XP002930084 *
See also references of EP1175431A4 *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1436405A4 (en) * 2001-08-20 2006-01-04 Whatman Inc Dna purification and recovery from high particulate and solids samples
EP1436405A2 (en) * 2001-08-20 2004-07-14 Whatman Inc. Dna purification and recovery from high particulate and solids samples
US6972329B2 (en) 2001-11-15 2005-12-06 Whatman, Inc. Materials and methods for releasing genetic material
EP1453484A2 (en) * 2001-11-15 2004-09-08 Whatman, Inc. Methods and materials for detecting genetic material
EP1451320A4 (en) * 2001-11-15 2005-03-02 Whatman Inc Materials and methods for releasing genetic material
EP1453484A4 (en) * 2001-11-15 2005-03-09 Whatman Inc Methods and materials for detecting genetic material
EP1451320A2 (en) * 2001-11-15 2004-09-01 Whatman Inc. Materials and methods for releasing genetic material
US7504363B2 (en) 2001-11-15 2009-03-17 Whatman, Inc. Methods using four-layer filter for PCR sample preparation
US11572581B2 (en) 2002-06-07 2023-02-07 DNA Genotek, Inc. Compositions and methods for obtaining nucleic acids from sputum
WO2003106031A1 (en) * 2002-06-12 2003-12-24 F. Hoffmann-La Roche Ag Method and device for detecting the presence of an analyte in a test sample
JP2013515494A (en) * 2009-12-29 2013-05-09 ワットマン インコーポレイテッド Improved nucleic acid elution
US11002646B2 (en) 2011-06-19 2021-05-11 DNA Genotek, Inc. Devices, solutions and methods for sample collection
US11592368B2 (en) 2011-06-19 2023-02-28 DNA Genotek, Inc. Method for collecting and preserving a biological sample
US11549870B2 (en) 2011-06-19 2023-01-10 DNA Genotek, Inc. Cell preserving solution
US11536632B2 (en) 2011-06-19 2022-12-27 DNA Genotek, Inc. Biological collection system
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US10625242B2 (en) 2012-04-30 2020-04-21 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
US10435735B2 (en) 2014-03-07 2019-10-08 Dna Genotek Inc. Composition and method for stabilizing nucleic acids in biological samples
US11198899B2 (en) 2014-03-07 2021-12-14 Dna Genotek Inc. Composition and method for stabilizing nucleic acids in biological samples
US11266337B2 (en) 2015-09-09 2022-03-08 Drawbridge Health, Inc. Systems, methods, and devices for sample collection, stabilization and preservation
CN105907751A (en) * 2016-06-27 2016-08-31 河南农业大学 FTA (flinders technology associates)-card-based method for extracting Cryptosporidium oocyst DNA from feces
US10638963B2 (en) 2017-01-10 2020-05-05 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
US10888259B2 (en) 2017-01-10 2021-01-12 Drawbridge Health, Inc. Cartridge assemblies for storing biological samples
US10932710B2 (en) 2017-01-10 2021-03-02 Drawbridge Health, Inc. Carriers for storage and transport of biological samples
US11298060B2 (en) 2017-01-10 2022-04-12 Drawbridge Health, Inc. Devices for collecting biological samples

Also Published As

Publication number Publication date
EP1175431A4 (en) 2002-09-11
AU4353500A (en) 2000-11-17
EP1175431A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
EP1173623B1 (en) Solid medium and process for the storage and rapid purification of nucleic acid
US6090936A (en) Device for isolating nucleic acids
EP1563091B2 (en) Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems
EP1175431A1 (en) Substrate including anionic detergent for purifying nucleic acid
EP1119576B1 (en) Isolation method for nucleic acid and apparatus
US8008475B1 (en) Method for isolating and purifying nucleic acids on surfaces
KR0148693B1 (en) Nucleic Acid Isolation Method
US7173124B2 (en) Isolation of nucleic acid
US5783686A (en) Method for purifying nucleic acids from heterogenous mixtures
US20090043087A1 (en) DNA purification and recovery from high particulate and solids samples
US5447864A (en) Capture method for cell nucei using a DNA mesh
WO2005068628A2 (en) Methods for nucleic acid isolation and kits using solid phase material
JP2001501527A (en) Improved filtration system and method
CN101113437A (en) Isolation of rna and DNA from a biological sample
CA2319665A1 (en) Processes for isolating, amplifying and characterizing dna
WO2002063042A1 (en) Apparatus for isolating nucleic acid or biological material
GB2346370A (en) A method for isolating nucleic acids from cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000923408

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000923408

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000923408

Country of ref document: EP